Lower Urinary Track Symptoms Clinical Trials

6 recruiting

Lower Urinary Track Symptoms Trials at a Glance

6 actively recruiting trials for lower urinary track symptoms are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Boston, Bristol, and Hamar. Lead sponsors running lower urinary track symptoms studies include Benaroya Research Institute, Beth Israel Deaconess Medical Center, and Centre hospitalier de l'Université de Montréal (CHUM).

Browse lower urinary track symptoms trials by phase

Treatments under study

About Lower Urinary Track Symptoms Clinical Trials

Looking for clinical trials for Lower Urinary Track Symptoms? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Lower Urinary Track Symptoms trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Lower Urinary Track Symptoms clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting
Not Applicable

Outcome and Patient Experiences After Transurethral Resection and Bipolar Enucleation of the Prostate - a Multi-center, Randomized Controlled Trial.

Lower Urinary Track SymptomsBenign Prostate Obstruction (BPO)
Sykehuset Innlandet HF120 enrolled2 locationsNCT07562386
Recruiting

e-Sense® Normal Values of Urodynamic Pressures Using e-Sense® Catheters

Lower Urinary Track SymptomsUrodynamic Exam
Laborie Medical Technologies Inc.40 enrolled1 locationNCT06905808
Recruiting
Phase 2

New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic Hyperplasia

Lower Urinary Track SymptomsBPH (Benign Prostatic Hyperplasia)
Beth Israel Deaconess Medical Center242 enrolled1 locationNCT06944145
Recruiting

Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer (X-SMILE)

Prostate Cancer (Adenocarcinoma)Localized Prostate CarcinomaProstate Hyperplasia+1 more
University of Zurich75 enrolled3 locationsNCT06834152
Recruiting

Intradetrusor Onabotulinumtoxin A (Botox) at the Time of Transurethral Resection of the Prostate or Transurethral Waterjet Ablation of the Prostate for Mixed Lower Urinary Tract Symptoms

Lower Urinary Track SymptomsBenign Prostatic Hypertrophy (BPH)
Benaroya Research Institute20 enrolled1 locationNCT07377929
Recruiting
Not Applicable

Evaluation of the Optilume BPH Catheter System and the Rezum Water Vapor Therapy in Treating Benign Prostatic Hyperplasia

Lower Urinary Track SymptomsBenign Prostatic Hyperplasia (BPH)
Centre hospitalier de l'Université de Montréal (CHUM)100 enrolled1 locationNCT06769997